Immunic Inc
NASDAQ:IMUX
Immunic Inc
NASDAQ:IMUX
Price:
1.17
USD
9.35%
Market Closed
Market Cap:
$140.7m
Balance Sheet
Balance Sheet Decomposition
Immunic Inc
Immunic Inc
Balance Sheet Decomposition is not available for
Immunic Inc
Immunic Inc
Balance Sheet
Immunic Inc
Immunic Inc
Currency: USD
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
1
|
5
|
38
|
102
|
83
|
60
|
57
|
13
|
29
|
128
|
87
|
107
|
47
|
36
|
15
|
|
| Cash Equivalents |
1
|
5
|
38
|
102
|
83
|
60
|
57
|
13
|
29
|
128
|
87
|
107
|
47
|
36
|
15
|
|
| Short-Term Investments |
0
|
14
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Current Assets |
0
|
1
|
6
|
3
|
2
|
2
|
1
|
1
|
3
|
6
|
18
|
9
|
4
|
3
|
7
|
|
| Total Current Assets |
1
|
19
|
44
|
105
|
85
|
62
|
58
|
14
|
32
|
134
|
105
|
126
|
53
|
39
|
23
|
|
| PP&E Net |
1
|
1
|
3
|
3
|
4
|
3
|
2
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
|
| PP&E Gross |
1
|
1
|
3
|
3
|
4
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
4
|
5
|
6
|
7
|
8
|
10
|
10
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
33
|
33
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
33
|
33
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
20
+915%
|
47
+130%
|
108
+132%
|
89
-18%
|
64
-28%
|
60
-6%
|
15
-75%
|
66
+340%
|
168
+154%
|
139
-17%
|
128
-8%
|
54
-58%
|
41
-25%
|
24
-41%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
4
|
4
|
4
|
5
|
8
|
10
|
|
| Accrued Liabilities |
1
|
1
|
3
|
9
|
5
|
5
|
9
|
2
|
3
|
4
|
8
|
9
|
19
|
14
|
19
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
2
|
2
|
7
|
10
|
7
|
6
|
10
|
3
|
7
|
8
|
11
|
13
|
25
|
22
|
31
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
2
-18%
|
8
+333%
|
11
+35%
|
7
-35%
|
6
-18%
|
10
+84%
|
3
-75%
|
8
+192%
|
9
+20%
|
12
+32%
|
14
+18%
|
25
+80%
|
22
-12%
|
31
+37%
|
|
| Equity | ||||||||||||||||
| Common Stock |
55
|
26
|
84
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
64
|
70
|
103
|
151
|
203
|
244
|
296
|
337
|
60
|
104
|
197
|
317
|
411
|
511
|
609
|
|
| Additional Paid In Capital |
9
|
63
|
58
|
248
|
285
|
302
|
346
|
350
|
120
|
267
|
324
|
428
|
436
|
526
|
599
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
0
|
3
|
4
|
4
|
3
|
|
| Total Equity |
0
N/A
|
19
N/A
|
39
+110%
|
98
+152%
|
82
-16%
|
58
-29%
|
50
-14%
|
12
-75%
|
58
+371%
|
159
+172%
|
127
-20%
|
114
-11%
|
29
-75%
|
18
-36%
|
7
N/A
|
|
| Total Liabilities & Equity |
2
N/A
|
20
+915%
|
47
+130%
|
108
+132%
|
89
-18%
|
64
-28%
|
60
-6%
|
15
-75%
|
66
+340%
|
168
+154%
|
139
-17%
|
128
-8%
|
54
-58%
|
41
-25%
|
24
-41%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
11
|
21
|
26
|
39
|
45
|
90
|
120
|
|
Switch to:
Switch to:
See Also
Discover More
